Filing Flows › Comparisons › MRVI vs NUVB
Maravai Lifesciences Holdings vs Nuvation Bio: MRVI and NUVB compared
Maravai Lifesciences Holdings is the larger company: $45.9M of revenue in its latest quarter (Q3 2026) against $45.0M for Nuvation Bio (Q3 2026). Nuvation Bio is growing faster (+243% against +10% a year earlier). Maravai Lifesciences Holdings is more profitable, with an operating margin of -45.0% against -93.9%.
Where the money goes: MRVI and NUVB
Maravai Lifesciences Holdings (MRVI) · Q3 2026
Maravai Lifesciences Holdings, Q3 2026: revenue $45.9M (+10% year over year), operating margin -45.0%, net loss $24.0M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Nuvation Bio (NUVB) · Q3 2026
Nuvation Bio, Q3 2026: revenue $45.0M (+243% year over year), operating margin -93.9%, net loss $41.9M, operating cash flow −$38.6M. The chart follows the revenue to costs, profit and cash.
| Maravai Lifesciences Holdings (MRVI) | Nuvation Bio (NUVB) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $45.9M | $45.0M |
| Revenue growth, Y/Y | +10% | +243% |
| Operating margin | -45.0% | -93.9% |
| Net earnings | −$24.0M | −$41.9M |
| Net margin | -52.3% | -93.2% |
| Operating cash flow | $5.0M | −$38.6M |
| Free cash flow | $4.5M | — |
| Market value | — | $1.5B |
| Analysts’ mean target | — | $13.00 |
Where the revenue comes from
Maravai Lifesciences Holdings
- TriLink: $28.4M (62%)
- Cygnus: $17.5M (38%)
Nuvation Bio
- Product Revenue: $27.5M (61%)
- License: $17.5M (39%)
Questions
Which is bigger, Maravai Lifesciences Holdings or Nuvation Bio?
Maravai Lifesciences Holdings is the larger company: $45.9M of revenue in its latest quarter (Q3 2026) against $45.0M for Nuvation Bio (Q3 2026).
Is Maravai Lifesciences Holdings or Nuvation Bio growing faster?
Nuvation Bio is growing faster (+243% against +10% a year earlier).
Which is more profitable, Maravai Lifesciences Holdings or Nuvation Bio?
Maravai Lifesciences Holdings is more profitable, with an operating margin of -45.0% against -93.9%.
More: Maravai Lifesciences Holdings earnings · how Maravai Lifesciences Holdings makes money · Nuvation Bio earnings · how Nuvation Bio makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.